A share price of Sana Biotechnology Inc [SANA] is currently trading at $10.00, saw in change for the day. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SANA shares have gain 9.29% over the last week, with a monthly amount drifted -6.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 29, February 2024, Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates. In a post published today on Yahoo Finance, Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes.
From an analyst’s perspective:
Sana Biotechnology Inc [NASDAQ: SANA] stock has seen the most recent analyst activity on January 16, 2024, when H.C. Wainwright upgraded its rating to a Buy but kept the price target unchanged to $12 for it. Previously, JMP Securities started tracking the stock with Mkt Outperform rating on September 25, 2023, and set its price target to $9. On September 05, 2023, Citigroup initiated with a Buy rating and assigned a price target of $8 on the stock. TD Cowen started tracking the stock assigning a Market Perform rating. H.C. Wainwright initiated its recommendation with a Neutral. Morgan Stanley started tracking with a Overweight rating for this stock on March 01, 2021, and assigned it a price target of $40. In a note dated March 01, 2021, JP Morgan initiated an Neutral rating and provided a target price of $35 on this stock.
Sana Biotechnology Inc experienced fluctuations in its stock price throughout the past year between $2.74 and $12.00. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Sana Biotechnology Inc [NASDAQ: SANA] shares were valued at $10.00 at the most recent close of the market. An investor can expect a potential return of 20.0% based on the average SANA price forecast.
Analyzing the SANA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.78 and Total Capital is -0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.80 points at the first support level, and at 9.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.16, and for the 2nd resistance point, it is at 10.32.
Sana Biotechnology Inc [SANA] reported earnings per share of -$0.41 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.38/share, meaning a difference of -$0.03 and a surprise factor of -7.90%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.02 per share as compared to estimates of -$0.45 per share, a difference of $0.47 representing a surprise of 104.40%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sana Biotechnology Inc [NASDAQ:SANA] is 3.31. Further, the Quick Ratio stands at 3.31, while the Cash Ratio is 2.13.
Transactions by insiders
Recent insider trading involved Yang Patrick Y, Director, that happened on Mar 08 ’24 when 25000.0 shares were sold. Director, NELSEN ROBERT completed a deal on Feb 08 ’24 to buy 1.82 million shares. Meanwhile, 10% Owner ARCH Venture Fund X, L.P. bought 1.82 million shares on Feb 08 ’24.
